Skip to main content

Table 3 Clinical and biochemical characteristics of the Kazakh study cohorts matched for age

From: Association between 28 single nucleotide polymorphisms and type 2 diabetes mellitus in the Kazakh population: a case-control study

  Control subjects Type 2 diabetic subjects P-value
N 141 223  
Male,% (n) 41,1% (58) 46,6% (104) 0.39
Age, years 52 (43–61) 53 (40–63) 0.11
Weight, kg 72 (47–125) 82 (46–135) <10−5
Height, cm 165 (140–192) 166 (148–188) 0.31
BMI, kg/m2 26.56 (17.2–43.1) 29.74 (18.4–47.2) <10−5
Systolic blood pressure, mm Hg 120 (90–140) 130.0 (100–220) <10−5
Diastolic blood pressure, mm Hg 80 (60–90) 80 (60–130) <10−5
Waist circumference, cm 89 (60–180) 94 (60–160) 0.01
Hip circumference, cm - 100 (63–165) -
Waist/hip ratio - 0.95 (0.54–1.83) -
Glucose, mmol/L 5.15 (3.8–6.5) 9.2 (4.1–30.5) <10−5
Cholesterol, mmol/L 4.9 (2.4–11.8) 5.2 (2.8–16.7) 0.12
Triglycerides, mmol/L 1.2 (0.4–3.8) 1.9 (0.2–17.6) <10−5
Low-density lipoproteins, mmol/L 4.57 (1.78–15.50) 4.71 (1.56–8.67) 0.47
High-density lipoproteins, mmol/L 1.32 (0.7–2.8) 1.23 (0.62–3.6) 0.009
HbA1c, % 5.9 (4.5–6.7) 7.65 (4.4–16.4) <10−5
Insulin, μIU/mL - 12.70 (0.02–97.0) -
C-peptide, ng/mL - 4.20 (0.14–12.0) -
  1. Data are expressed as median (range) unless otherwise specified